Loading...

AMPH AMPHASTAR PHARMACEUTICALS INC Expansion Plans 8-K Filing

MPHS

MPH

AMPHASTAR PHARMACEUTICALS INC

(AMPH)

2024 8-K

Show Summary

Summary

New Research Agreement

Financial Statements

Financial Statements

Financial Results

Q3 Earnings Report

Distribution Agreement

Financial Results Announcement

Annual Meeting and Share Bu...

Earnings Reports

Financial Results Announcement

Earnings Report

Purchase Agreement

Financial Results Announcement

Credit Agreement and Acquis...

Annual Meeting Voting Results

Financial Results Announcement

Asset Purchase Agreement

Amendment to Contract Resea...

Financial Results Announcement

Amended and Restated Bylaws...

External Links:

Amphastar Pharmaceuticals has entered a 10-year distribution agreement with Genreach to market its inhalation product, Primatene MIST, in Greater China, expecting total revenue of $10 million from the deal.

AI Assistant

AMPHASTAR PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.